Article Details

FDA Approves Roche's Susvimo for Continuous Delivery Treatment of Diabetic Retinopathy

Retrieved on: 2025-06-02 14:03:51

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Roche's Susvimo for Continuous Delivery Treatment of Diabetic Retinopathy. View article details on hiswai:

Excerpt

The U.S. Food and Drug Administration (FDA) has approved Roche's Susvimo as a treatment for diabetic retinopathy, marking the first continuous ...

Article found on: www.geneonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo